- Home
- BBWI
as of 03-10-2026 3:48pm EST
$20.57
$0.93
-4.33%
Bath & Body Works is a specialty home fragrance and fragrant body care retailer operating under the Bath & Body Works, C.O. Bigelow, and White Barn brands. The company generates most of its business in North America, with just 5% of sales from international markets in fiscal 2024. For fiscal 2024, 76% of sales stemmed from the brick-and-mortar network (which was composed of more than 1,800 retail stores), similar to 2023 levels, as consumer shopping patterns remained to normal. Future growth is expected from store upgrades, digital and international channels, as well as adjacent category expansions like men's and lip.
| Founded: | 1963 | Country: | United States |
| Employees: | N/A | City: | COLUMBUS |
| Market Cap: | 4.0B | IPO Year: | 1994 |
| Target Price: | $25.61 | AVG Volume (30 days): | 5.1M |
| Analyst Decision: | Hold | Number of Analysts: | 16 |
| Dividend Yield: | Dividend Payout Frequency: | monthly | |
| EPS: | 1.17 | EPS Growth: | -5.99 |
| 52 Week Low/High: | $14.28 - $34.29 | Next Earning Date: | 06-02-2026 |
| Revenue: | $7,307,000,000 | Revenue Growth: | -1.64% |
| Revenue Growth (this year): | -1.84% | Revenue Growth (next year): | 2.91% |
| P/E Ratio: | 17.58 | Index: | N/A |
| Free Cash Flow: | 660.0M | FCF Growth: | +31.06% |
AI-Powered BBWI Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated 2 days ago
AI Recommendation
hold
Model Accuracy: 72.05%
72.05%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Earnings Transcripts
SEC 8-K filings with transcript text
2025 Q4 Q4 2025 Earnings
8-K SELL Mar 4, 2026 · 100% conf.
2025
Q4
Q4 2025 Earnings
8-K SELLMar 4, 2026 · 100% conf.
AI Prediction SELL
1D
-1.15%
$22.68
5D
-5.79%
$21.61
20D
-2.00%
$22.48
Price: $22.94 Prob +5D: 0% AUC: 1.000
0000701985-26-000005
bbwi-202603040000701985false00007019852026-03-042026-03-04
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): March 4, 2026
Bath & Body Works, Inc. (Exact name of registrant as specified in its charter)
Delaware (State or other jurisdiction of incorporation)
1-834431-1029810 (Commission File Number)(IRS Employer Identification No.)
Three Limited Parkway Columbus,OH43230 (Address of principal executive offices)(Zip Code)
(614) 415-7000 Registrant's telephone number, including area code
Not Applicable (Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered Common Stock, $0.50 Par ValueBBWIThe New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02. Results of Operations and Financial Condition and Item 7.01. Regulation FD Disclosure. The following information, including Exhibit 99.1, is being furnished pursuant to Item 2.02, “Results of Operations and Financial Condition” and Item 7.01, “Regulation FD Disclosure” and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing. On March 4, 2026, Bath & Body Works, Inc. issued a press release setting forth its unaudited financial results for the fourth quarter and full-year 2025. In addition, the press release provides first quarter and full-year 2026 earnings guidance. A copy of the press release is attached hereto as Exhibit 99.1 and is hereby incorporated by reference. Item 9.01. Financial Statements and Exhibits. Exhibit 99.1 Press Release of Bath & Body Works, Inc., dated March 4, 2026. Exhibit 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Bath & Body Works, Inc.
Date:March 4, 2026By:/s/ EVA C. BORATTO Eva C. Boratto Chief Financial Officer
2025 Q3 Q3 2025 Earnings
8-K Nov 20, 2025
2025
Q3
Q3 2025 Earnings
8-KNov 20, 2025
0000701985-25-000033
bbwi-202511200000701985false00007019852025-11-202025-11-20
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): November 20, 2025
Bath & Body Works, Inc. (Exact Name of Registrant as Specified in Its Charter)
Delaware (State or Other Jurisdiction of Incorporation)
1-834431-1029810 (Commission File Number)(IRS Employer Identification No.)
Three Limited Parkway Columbus,OH43230 (Address of Principal Executive Offices)(Zip Code)
(614) 415-7000 (Registrant's Telephone Number, Including Area Code)
Not Applicable (Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered Common Stock, $0.50 Par ValueBBWIThe New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02. Results of Operations and Financial Condition and Item 7.01. Regulation FD Disclosure. The following information, including Exhibit 99.1, is being furnished pursuant to Item 2.02, “Results of Operations and Financial Condition” and Item 7.01, “Regulation FD Disclosure” and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing. On November 20, 2025, Bath & Body Works, Inc. issued a press release setting forth its unaudited financial results for the third quarter of 2025 and its earnings guidance for the fourth quarter of 2025. In addition, the press release contains updated earnings guidance for the full-year 2025. A copy of the press release is attached hereto as Exhibit 99.1 and is hereby incorporated by reference. Item 9.01. Financial Statements and Exhibits. Exhibit 99.1 Press Release of Bath & Body Works, Inc., dated November 20, 2025. Exhibit 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Bath & Body Works, Inc.
Date:November 20, 2025By:/s/ EVA C. BORATTO Eva C. Boratto Chief Financial Officer
2025 Q2 Q2 2025 Earnings
8-K Aug 28, 2025
2025
Q2
Q2 2025 Earnings
8-KAug 28, 2025
0000701985-25-000028
bbwi-202508280000701985false00007019852025-08-282025-08-28
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): August 28, 2025
Bath & Body Works, Inc. (Exact Name of Registrant as Specified in Its Charter)
Delaware (State or Other Jurisdiction of Incorporation)
1-834431-1029810 (Commission File Number)(IRS Employer Identification No.)
Three Limited Parkway Columbus,OH43230 (Address of Principal Executive Offices)(Zip Code)
(614) 415-7000 (Registrant's Telephone Number, Including Area Code)
Not Applicable (Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered Common Stock, $0.50 Par ValueBBWIThe New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02. Results of Operations and Financial Condition and Item 7.01. Regulation FD Disclosure. The following information, including Exhibit 99.1, is being furnished pursuant to Item 2.02, “Results of Operations and Financial Condition” and Item 7.01, “Regulation FD Disclosure” and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing. On August 28, 2025, Bath & Body Works, Inc. issued a press release setting forth its unaudited financial results for the second quarter of 2025 and its earnings guidance for the third quarter of 2025. In addition, the press release contains updated earnings guidance for the full-year 2025. A copy of the press release is attached hereto as Exhibit 99.1 and is hereby incorporated by reference. Item 9.01. Financial Statements and Exhibits. Exhibit 99.1 Press Release of Bath & Body Works, Inc., dated August 28, 2025. Exhibit 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Bath & Body Works, Inc.
Date:August 28, 2025By:/s/ Eva C. Boratto Eva C. Boratto Chief Financial Officer
Latest Bath & Body Works Inc. News
BBWI Breaking Stock News: Dive into BBWI Ticker-Specific Updates for Smart Investing
Morningstar Research
Analyst Report: Bath & Body Works, Inc.
Retail Insight Network
Bath & Body Works posts lower Q4 sales, forecasts further decline in 2026
The Wall Street Journal
Stocks to Watch Wednesday Recap: Coinbase, Meta, Gitlab, Bath & Body Works
Compare BBWI vs Leading Stocks
See how BBWI stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "BBWI Bath & Body Works Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.